A Phase 3 Study of Tenofovir Alafenamide (TAF) Compared With Tenofovir Disoproxil Fumarate (TDF) in Patients With HBeAg-negative, Chronic Hepatitis B (CHB): Week 48 Efficacy and Safety Results
Titel:
A Phase 3 Study of Tenofovir Alafenamide (TAF) Compared With Tenofovir Disoproxil Fumarate (TDF) in Patients With HBeAg-negative, Chronic Hepatitis B (CHB): Week 48 Efficacy and Safety Results
Auteur:
Lik-Yuen Chan, Henry Fung, Scott Seto, Wai Kay Chuang, Wan-Long Chen, Chi-Yi Kim, Hyung Joon Hui, Aric Josun Janssen, Harry Chowdhury, Abhijit Owen Tsang, Tak Yin Mehta, Rajiv Gane, Edward Lim, Seng Gee Flaherty, John F. Massetto, Benedetta Kitrinos, Kathryn Dinh, Phillip Subramanian, Mani McHutchison, John Lu, Yiwei Lim, Young-Suk Acharya, Sibrat Agarwal, Kosh